Abstract
One of the main limitations during low-kV IORT (intraoperative radiotherapy) with dedicated spherical applicators is the long treatment time. Employing nanoparticles (NPs) can reduce the treatment time through increasing the absorbed dose by the irradiated volume. The current study aims to evaluate and compare the efficacy of different clinically recommended NP types in dose enhancement during low-kV IORT using a Monte Carlo simulation approach.The INTRABEAM, a dedicated IORT machine, including the bare probe along with 2 and 4 cm diameter spherical applicators was simulated by MCNPX Monte Carlo code and dose enhancement factor (DEF) in presence of eight different NP types of Silver (Ag), Gold (Au), Bismuth (Bi), Iron (Fe), Gadolinium (Gd), Hafnium (Hf), Platinum (Pt), and Titanium (Ti) with two concentrations of 0.5% (5 mg/g) and 2% (20 mg/g) were calculated inside the water.The results demonstrated that the Bi nanoparticle has the most desirable efficacy in dose enhancement within the target region as well as protection of underlying healthy tissues, especially at 2% concentration. Ag, Au, Hf, and Pt NPs have also a good performance in dose enhancement within the tumor volume, but at expense of higher absorbed dose by underlying healthy tissues.From the results, it can be concluded that employing the NPs during low energy X-ray IORT can considerably reduce the treatment time, a fact that can increase the lifetime of the IORT machine as well as improve the anesthetized patient manipulation irradiated inside the operating room.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.